In an interview with Nutritional Outlook, Sameena Rahman, MD, a board-certified OB/GYN, discusses why the shift from Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome reflects growing recognition of the condition’s links to insulin resistance, inflammation, cardiovascular risk, and lifelong metabolic health.